Enoxaparin - NDC Database (Page 7)

191 records found
Page:First PagePrevious Page7Next PageLast Page
63323-568 Mar 15, 2015
Enoxaparin Sodium 100 mg/ml Subcutaneous Injection by Fresenius Kabi USA, LLC
63323-569 Mar 15, 2015
Enoxaparin Sodium 150 mg/ml Subcutaneous Injection by Fresenius Kabi USA, LLC
63323-584 Apr 23, 2019
Enoxaparin Sodium 80 mg/.8ml Subcutaneous Injection by Fresenius Kabi USA, LLC
63323-586 Apr 23, 2019
Enoxaparin Sodium 100 mg/ml Subcutaneous Injection by Fresenius Kabi USA, LLC
63323-589 Apr 23, 2019
Enoxaparin Sodium 150 mg/ml Subcutaneous Injection by Fresenius Kabi USA, LLC
63323-605 Jul 15, 2019
Enoxaparin Sodium 100 mg/ml Subcutaneous Injection by Fresenius Kabi USA, LLC
63323-607 Jul 15, 2019
Enoxaparin Sodium 60 mg/.6ml Subcutaneous Injection by Fresenius Kabi USA, LLC
63323-609 Jul 15, 2019
Enoxaparin Sodium 120 mg/.8ml Subcutaneous Injection by Fresenius Kabi USA, LLC
63323-655 May 01, 2019
Enoxaparin Sodium 120 mg/.8ml Subcutaneous Injection by Fresenius Kabi USA, LLC
68001-457 Oct 19, 2020
Enoxaparin Sodium 100 mg/ml Subcutaneous Injection by Bluepoint Laboratories
68001-458 Oct 19, 2020
Enoxaparin Sodium 100 mg/ml Subcutaneous Injection by Bluepoint Laboratories
68001-459 Oct 19, 2020
Enoxaparin Sodium 100 mg/ml Subcutaneous Injection by Bluepoint Laboratories
68001-460 Oct 19, 2020
Enoxaparin Sodium 100 mg/ml Subcutaneous Injection by Bluepoint Laboratories
68001-461 Oct 19, 2020
Enoxaparin Sodium 100 mg/ml Subcutaneous Injection by Bluepoint Laboratories
68001-462 Oct 19, 2020
Enoxaparin Sodium 150 mg/ml Subcutaneous Injection by Bluepoint Laboratories
68001-463 Oct 19, 2020
Enoxaparin Sodium 150 mg/ml Subcutaneous Injection by Bluepoint Laboratories
68001-464 Oct 19, 2020
Enoxaparin Sodium 300 mg/3ml Intravenous; Subcutaneous Injection by Bluepoint Laboratories
68001-633 Apr 16, 2025
Enoxaparin Sodium 100 mg/ml Subcutaneous Injection by Bluepoint Laboratories
68001-634 Jan 15, 2025
Enoxaparin Sodium 100 mg/ml Subcutaneous Injection by Bluepoint Laboratories
68001-635 Apr 15, 2025
Enoxaparin Sodium 100 mg/ml Subcutaneous Injection by Bluepoint Laboratories
Page:First PagePrevious Page7Next PageLast Page
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.